Open AccessDaily low dose of tadalafil improves pain and frequency in bladder pain syndrome/interstitial cystitis patients
Author(s) -
Pedro AbreuMendes,
Nuno Dias,
Jose Simaes,
Paulo Dinis,
Francisco Cruz,
Rui Pinto
Publication year - 2022
Publication title -
türk üroloji dergisi/turkish journal of urology
Language(s) - English
DOI - 10.5152/tud.2022.21292
Subject(s) - interstitial cystitis , medicine , tolerability , tadalafil , urology , bladder pain syndrome , nocturia , international prostate symptom score , pathophysiology , cgmp specific phosphodiesterase type 5 , nociception , urinary system , erectile dysfunction , overactive bladder , quality of life (healthcare) , adverse effect , neuromodulation , anesthesia , lower urinary tract symptoms , prostate , central nervous system , pathology , receptor , alternative medicine , nursing , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom